TerraCom Limited (TER.AX)

TerraCom Limited (TER.AX) stock comprehensive Forecast and Price Target with Analyst Ratings, Revenue Estimates, and complete financial and advanced discounted cashflow forecasts for up to 10 years.

Trending:

TerraCom Limited (TER.AX) Stock Forecast & Price Prediction | Analyst Ratings

Analyze DCF forecasts for the company and compare them with competitors.

Revenue

281.98M

Lower than competitor

Worse than CRN.AX's revenue of 4.66B.

Revenue Growth Rate

8.81%

Higher than competitor

Better than CRN.AX's revenue growth rate of 0.74%.

EBITDA

65.75M

Lower than competitor

Worse than CRN.AX's ebitda of 934.58M.

EBITDA Margin

23.32%

Higher than competitor

Better than CRN.AX's ebitda margin of 20.06%.

EBIT

48.64M

Lower than competitor

Worse than CRN.AX's ebit of 562.38M.

EBIT Margin

17.25%

Higher than competitor

Better than CRN.AX's ebit margin of 12.07%.

Depreciation

17.12M

Lower than competitor

Better than CRN.AX's depreciation of 372.19M.

Total Cash

13.40M

Lower than competitor

Worse than CRN.AX's total cash of 436.46M.

Cash as Percentage of Revenue

4.75%

Lower than competitor

Worse than CRN.AX's cash as percentage of revenue of 9.37%.

Receivables

26.60M

Lower than competitor

Better than CRN.AX's receivables of 568.24M.

Receivables as Percentage of Revenue

9.43%

Lower than competitor

Better than CRN.AX's receivables as percentage of revenue of 12.20%.

Inventories

10.70M

Lower than competitor

Better than CRN.AX's inventories of 294.40M.

Inventories as Percentage of Revenue

3.79%

Lower than competitor

Better than CRN.AX's inventories as percentage of revenue of 6.32%.

Accounts Payable

46.06M

Lower than competitor

Better than CRN.AX's accounts payable of 170.28M.

Payables as Percentage of Revenue

16.34%

Higher than competitor

Worse than CRN.AX's payables as percentage of revenue of 3.65%.

Capital Expenditure

-10.00M

Higher than competitor

Worse than CRN.AX's capital expenditure of -321.26M.

CapEx as Percentage of Revenue

-3.54%

Higher than competitor

Worse than CRN.AX's capex as percentage of revenue of -6.90%.

Weighted Average Cost of Capital (WACC)

8.27%

Lower than competitor

Better than CRN.AX's weighted average cost of capital (wacc) of 9.93%.

Cost of Equity

6.31%

Lower than competitor

Better than CRN.AX's cost of equity of 8.09%.

Cost of Debt

104.05%

Higher than competitor

Worse than CRN.AX's cost of debt of 17.74%.

Beta

0.36

Lower than competitor

Better than CRN.AX's beta of 0.74.

Diluted Shares Outstanding

800.97M

Lower than competitor

Better than CRN.AX's diluted shares outstanding of 1.68B.

Total Debt

4.18M

Lower than competitor

Better than CRN.AX's total debt of 518.89M.

Total Equity

152.18M

Lower than competitor

Worse than CRN.AX's total equity of 1.27B.

Total Capital

156.36M

Lower than competitor

Worse than CRN.AX's total capital of 1.79B.

Debt Weighting

2.67%

Lower than competitor

Better than CRN.AX's debt weighting of 29.02%.

Equity Weighting

97.33%

Higher than competitor

Better than CRN.AX's equity weighting of 70.98%.

EBIAT

37.25M

Lower than competitor

Worse than CRN.AX's ebiat of 457.53M.

Unlevered Free Cash Flow

53.03M

Lower than competitor

Worse than CRN.AX's unlevered free cash flow of 503.40M.

Long-Term Growth Rate

0.50%

Equal to CRN.AX's long-term growth rate of 0.50%.

Terminal Value

817.64M

Lower than competitor

Worse than CRN.AX's terminal value of 5.48B.

Enterprise Value

767.27M

Lower than competitor

Worse than CRN.AX's enterprise value of 5.23B.

Net Debt

-4.17M

Higher than competitor

Worse than CRN.AX's net debt of -66.97M.

Equity Value

771.44M

Lower than competitor

Worse than CRN.AX's equity value of 5.29B.

Equity Value Per Share

0.96

Lower than competitor

Worse than CRN.AX's equity value per share of 3.15.

Select Metric for Chart